Merck & Co. Stock Hits Day High with Strong 3.27% Intraday Surge

Merck & Co., Inc. has experienced a notable increase of 3.27% on April 8, 2026, reaching an intraday high of USD 123.63. This performance stands out against the S&P 500, which gained 2.51% on the same day. Over the past week, Merck's stock has risen by 1.94%, while its one-month performance shows a significant increase of 6.38%. In the past year, Merck has demonstrated impressive growth, with a remarkable 56.02% increase compared to the S&P 500's 36.13%. Year-to-date, the stock has gained 17.02%, contrasting with the S&P 500's decline of 0.92%. Key financial metrics highlight Merck's strong market position, including a high return on capital employed (ROCE) of 22.52% and a low debt-to-EBITDA ratio of 1.58 times, indicating robust financial health. The company has consistently reported positive results over the last four quarters, with operating cash flow reaching USD 18,534 million and a dividend per share of USD 5.05. Overall, Merck's performance metrics reflect a solid standing in the pharmaceuticals and biotechnology industry.